Eun Jin Ju
Overview
Explore the profile of Eun Jin Ju including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park S, Kwon M, Ju E, Shin S, Park J, Ko E, et al.
Cancer Sci
. 2023 Aug;
114(9):3583-3594.
PMID: 37650703
Radiotherapy (RT) plays an important role in localized lung cancer treatments. Although RT locally targets and controls malignant lesions, RT resistance prevents RT from being an effective treatment for lung...
2.
Shin S, Ju E, Park J, Ko E, Kwon M, Lee H, et al.
Cancer Cell Int
. 2023 Aug;
23(1):172.
PMID: 37596639
Background: The B7-H3 protein, encoded by the CD276 gene, is a member of the B7 family of proteins and a transmembrane glycoprotein. It is highly expressed in various solid tumors,...
3.
NCK-associated protein 1 regulates metastasis and is a novel prognostic marker for colorectal cancer
Kwon M, Lee J, Park J, Park S, Ju E, Ko E, et al.
Cell Death Discov
. 2023 Jan;
9(1):7.
PMID: 36639705
Metastatic colorectal cancer (CRC) remains a substantial problem for mortality and requires screening and early detection efforts to increase survival. Epithelial-mesenchymal transition (EMT) and circulation of tumor cells in the...
4.
Shin S, Park Y, Park S, Ju E, Park J, Ko E, et al.
Adv Sci (Weinh)
. 2021 Oct;
8(23):e2102414.
PMID: 34664433
Human epidermal growth factor receptor 2 (HER2) is overexpressed in breast and gastric cancers and this causes poor clinical outcomes. Although both T-DM1 and Enhertu are approved as an HER2-targeting...
5.
Choi J, Ko E, Ju E, Park S, Park J, Shin S, et al.
Int J Radiat Biol
. 2020 Aug;
96(11):1413-1422.
PMID: 32856972
Purpose: Cancer stem cells (CSCs) are relatively resistant to radiation compared to their non-tumorigenic progeny. Ionizing radiation (IR) can expand the pool of CSCs that leads to more aggressive cancers,...
6.
Lee K, Ko E, Park Y, Park S, Ju E, Park J, et al.
Biomaterials
. 2020 Jun;
255:120151.
PMID: 32505033
Neoadjuvant radiotherapy has become an important therapeutic option for colorectal cancer (CRC) patients, whereas complete tumor response is observed only in 20-30% patients. Therefore, the development of diagnostic probe for...
7.
Shin S, Park S, Ju E, Park J, Ko E, Hwang J, et al.
Anticancer Res
. 2017 Dec;
38(1):287-293.
PMID: 29277785
Background/aim: To maximize success rate for development of HER2-targeted therapeutics, patient-derived xenograft (PDX) models reflecting HER2-positive gastric cancer (HER2 GC) patients were established. Materials And Methods: GC tissues obtained from...
8.
Shin S, Park S, Lee K, Ju E, Park J, Ko E, et al.
Oncol Rep
. 2017 Aug;
38(4):2259-2266.
PMID: 28849069
The incidence of hepatocellular carcinoma (HCC) has continued to increase worldwide, and advanced HCC is difficult to treat using the currently available therapeutics. Chemoradiotherapy with cisplatin (cis-diamminedichloroplatinum, CDDP) is expected...
9.
Lee K, Shin S, Lee J, Ju E, Park Y, Hwang J, et al.
Biomaterials
. 2017 Jul;
141:136-148.
PMID: 28688285
Designing nanocarriers with active targeting has been increasingly emphasized as for an ideal delivery mechanism of anti-cancer therapeutic agents, but the actualization has been constrained by lack of reliable strategy...
10.
Park S, Jwa E, Shin S, Ju E, Park I, Pak J, et al.
Int J Biochem Cell Biol
. 2016 Dec;
83:47-55.
PMID: 27923747
Tumor necrosis factor-related apoptosis-induced ligand (TRAIL) induces apoptosis selectively in cancer cells without affecting the majority of normal human cells. However, hepatocellular carcinoma (HCC) cells often display resistance to TRAIL-induced...